ARCHIVES

Control AC Hear Report On High Risk conference, Messer Survey

This article is from The Cancer Letter archive.

Vol. 01 No. 31 | September 6, 1974

Download PDF Visit The Full Archive

Related Articles

Broader Chemical Distribution By NCI Awaits Hew Bureaucracy; Recipients May Have To Pay

March 2, 1979

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008

NCI Renews City of Hope’s Comprehensive Cancer Center Designation.

May 30, 2008

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005